Skip to main content
. Author manuscript; available in PMC: 2009 Sep 25.
Published in final edited form as: Arch Neurol. 2007 Mar;64(3):371–376. doi: 10.1001/archneur.64.3.371

Table 1.

Clinical features of PGRN (+) and (−) subjects

Sex Age at onset Illness duration (years) STMS at scan *Diagnosis at the time of Scan Prominent symptoms up to the time of MRI scan Symptoms present over entire disease course (+ = present, 0 = absent)
Parkinsonism Language Behavior
PGRN (−)
1 F 64 13 25 bvFTD Personality change, apathy, loss of interest 0 0 +
2 F 62 8 34 bvFTD Anhedonic, lack of initiative, poor judgment 0 0 +
3 M 45 13 26 bvFTD Personality change, withdrawn, lack of initiative 0 0 +
4 F 68 3 NA CBS Parkinsonism, L>R limb apraxia + 0 0
5 F 64 6 34 bvFTD Changes in behavior and personality + 0 +
6 M 51 1 30 bvFTD Executive dysfunction, decreased personal hygiene, inappropriate laughter, compulsive behaviors + + +
7 F 59 7 26 SD Difficulty with naming of people and objects, and circumlocutions, behavioral changes 0 + +
8 F 77 6 31 bvFTD Personality change, executive dysfunction, & paranoia 0 0 +
PGRN (+)
9 M 69 7 28 bvFTD Executive dysfunction, loss of attention, & memory loss + + +
10 M 60 8 31 bvFTD Personality change, executive dysfunction & memory loss + + +
11 F 52 5 23 bvFTD Personality change, executive dysfunction, abulia, memory loss, and decrease word output & fluency + + +
12 M 49 6 27 CBS Parkinsonism, L>R limb apraxia + + 0
13 M 56 7 34 bvFTD Personality change + 0 +
14χ F 56 7 32 bvFTD Personality change, executive dysfunction & memory loss + + +
15χ F 61 NA NA SD Difficulty with naming of people, places, and things and comprehension problems 0 + 0
16 F 56 NA 22 bvFTD Executive dysfunction + + +

STMS = Short Test of Mental Status Score

*

Diagnosis based on Consensus criteria1,22

χ

Subjects still alive

Using Fishers Exact test p =0.05 for parkinsonism PGRN (−) v PGRN (+) (30% vs. 90%) and P = 0.02 for language (20% vs. 90%) using a one tail test (assuming that the feature would be more frequent in the PGRN (+) group).